Novo Nordisk’s shares fell sharply on Monday after the results from testing the Danish company’s CagriSema drug fell short of investors’ expectations.
Introducing the first partner Pokémon from #PokemonWindsWaves!
，详情可参考同城约会
Read full article
Global news & analysis